UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combined use of radiotherapy and tyrosine kinase inhibitors in the management of metastatic non-small cell lung cancer: A literature review

Critical reviews in oncology/hematology, 2024-12, Vol.204, p.104520, Article 104520

2024

Volltextzugriff (PDF)

Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy

European journal of cancer (1990), 2024-12, Vol.213, p.115065, Article 115065

2024

Volltextzugriff (PDF)

EP.14C.10 Clinical and Pathoanatomical Characteristics of Rare Pulmonary Neuroendocrine Tumors in Greek Population

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S701-S701

2024

Volltextzugriff (PDF)

EP.06D.05 The Prognostic Role of the Dynamic Changes in the Plasma ctDNA Levels in Advanced NSCLC after IO Initiation: A Meta-Analysis

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S503-S503

2024

Volltextzugriff (PDF)

Molecular Diagnostics and Treatment Patterns in Metastatic Non-small Cell Lung Cancer Patients: Real World Evidence from Greece: LACHESIS Study

Anticancer research, 2024-05, Vol.44 (5), p.2063-2072

2024

Volltextzugriff (PDF)

Lung Cancer Proteogenomics: Shaping the Future of Clinical Investigation

Cancers, 2024-03, Vol.16 (6), p.1236

2024

Volltextzugriff (PDF)

Robotic Bronchoscopy in Lung Cancer Diagnosis

Cancers, 2024-03, Vol.16 (6), p.1179

2024

Volltextzugriff (PDF)

Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets

Cancers, 2024-03, Vol.16 (6), p.1139

2024

Volltextzugriff (PDF)

77P Prognostic and predictive value of soluble PD-1 and PD-L1 in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors

ESMO open, 2024-03, Vol.9, p.102656, Article 102656

2024

Volltextzugriff (PDF)

The Gap of Health Inequalities Amongst Lung Cancer Patients of Different Socioeconomic Status: A Brief Reference to the Greek Reality

Cancers, 2024-02, Vol.16 (5), p.906

2024

Volltextzugriff (PDF)

Efficacité intracrânienne du sotorasib versus docétaxel dans le cancer bronchique non à petites cellules (CBNPC) métastatique muté KRAS G12C données utiles à la pratique issues d’un essai randomisé contrôlé

Revue des maladies respiratoires actualités, 2024-01, Vol.16 (1), p.265

2024

Volltextzugriff (PDF)

2046P The importance of communicating bad news in medical education

Annals of oncology, 2023-10, Vol.34, p.S1083-S1084

2023

Volltextzugriff (PDF)

2007P Real-world (rw) outcomes to chemoimmunotherapy and biomarker analysis in extensive-stage small cell lung cancer (ES SCLC)

Annals of oncology, 2023-10, Vol.34, p.S1069-S1069

2023

Volltextzugriff (PDF)

Exploring the Use of a Digital Platform for Cancer Patients to Report Their Demographics, Disease and Therapy Characteristics, Age, and Educational Disparities: An Early-Stage Feasibility Study

Current oncology (Toronto), 2023-08, Vol.30 (8), p.7608-7619

2023

Volltextzugriff (PDF)

Efficacy and safety of lurbinectedin in elderly patients with relapsed SCLC

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.8591-8591

2023

Volltextzugriff (PDF)

CDK4/6 inhibitors and cardiovascular toxicity: Real-world evidence

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e15074-e15074

2023

Volltextzugriff (PDF)

Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases

Cancers, 2023-05, Vol.15 (9), p.2637

2023

Volltextzugriff (PDF)

Efficacy of Tocilizumab in Severely Ill COVID-19 Patients With Rapid Respiratory Deterioration: A Single Center Experience During the Third Pandemic Wave in Greece

In vivo (Athens), 2023-05, Vol.37 (3), p.1312-1317

2023

Volltextzugriff (PDF)

155P Eligibility for lung cancer screening among patients diagnosed with lung cancer in Greece

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S125

2023

Volltextzugriff (PDF)

Evolving Treatment Landscape of HER2 -mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond

Cancers, 2023-02, Vol.15 (4), p.1286

2023

Volltextzugriff (PDF)

Evolving Treatment Landscape of IHER2/I-mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond

Cancers, 2023-02, Vol.15 (4)

2023

Volltextzugriff (PDF)

Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia

Cytokine (Philadelphia, Pa.), 2023-02, Vol.162, p.156111-156111, Article 156111

2023

Volltextzugriff (PDF)

1 – 25 von 623

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(478)
Mit Volltextzugriff
(558)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(331)
Life Sciences & Biomedicine
(324)
Humans
(299)
Oncology
(271)
Female
(149)
Male
(144)
Aged
(125)
Middle Aged
(121)
Biological And Medical Sciences
(113)
Medical Sciences
(110)
Lung Cancer
(100)
Tumors
(97)
Adult
(84)
Nuclear Medicine
(72)
Clinical & Internal Medicine
(71)
Prognosis
(64)
Treatment Outcome
(62)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(58)
Chemotherapy
(58)
Aged, 80 And Over
(54)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Combined use of radiotherapy and tyrosine kinase inhibitors in the management of metastatic non-small cell lung cancer: A literature review

Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy

Protection conferred by booster vaccine doses in hospitalized patients with COVID-19 during the SARS-CoV-2 Omicron BA.2 and BA.5 epidemics from 2022–2023 in Greece

EP.14C.10 Clinical and Pathoanatomical Characteristics of Rare Pulmonary Neuroendocrine Tumors in Greek Population

EP.06D.05 The Prognostic Role of the Dynamic Changes in the Plasma ctDNA Levels in Advanced NSCLC after IO Initiation: A Meta-Analysis

Molecular Diagnostics and Treatment Patterns in Metastatic Non-small Cell Lung Cancer Patients: Real World Evidence from Greece: LACHESIS Study

Lung Cancer Proteogenomics: Shaping the Future of Clinical Investigation

Robotic Bronchoscopy in Lung Cancer Diagnosis

Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets

77P Prognostic and predictive value of soluble PD-1 and PD-L1 in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors

The Gap of Health Inequalities Amongst Lung Cancer Patients of Different Socioeconomic Status: A Brief Reference to the Greek Reality

Efficacité intracrânienne du sotorasib versus docétaxel dans le cancer bronchique non à petites cellules (CBNPC) métastatique muté KRAS G12C données utiles à la pratique issues d’un essai randomisé contrôlé

2046P The importance of communicating bad news in medical education

2007P Real-world (rw) outcomes to chemoimmunotherapy and biomarker analysis in extensive-stage small cell lung cancer (ES SCLC)

Exploring the Use of a Digital Platform for Cancer Patients to Report Their Demographics, Disease and Therapy Characteristics, Age, and Educational Disparities: An Early-Stage Feasibility Study

Efficacy and safety of lurbinectedin in elderly patients with relapsed SCLC

CDK4/6 inhibitors and cardiovascular toxicity: Real-world evidence

Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases

Efficacy of Tocilizumab in Severely Ill COVID-19 Patients With Rapid Respiratory Deterioration: A Single Center Experience During the Third Pandemic Wave in Greece

Clinical Outcomes Beyond 1L EGFR -TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'

155P Eligibility for lung cancer screening among patients diagnosed with lung cancer in Greece

Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece

Evolving Treatment Landscape of HER2 -mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond

Evolving Treatment Landscape of IHER2/I-mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond

Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia

Suchergebnisse filtern